Home › Companies › HAEMONETICS CORP. › 2024-2025

HAEMONETICS CORP. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and HAEMONETICS CORP.’s Form 8-K, filed 2024-07-25 (Item 5.07 on EDGAR). Page generated 02 October 2026.

23Ballot items
353Asset managers
4,903Fund votes
2024-07-25Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore HAEMONETICS CORP. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by HAEMONETICS CORP.

These tallies are HAEMONETICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-07-25 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

HAEMONETICS CORP. — official shareholder meeting results, meeting held 2024-07-25
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Christopher A. Simon	47,563,311	--	--	269,386	1,079,553	Majority: yes
Elect Director: Robert E. Abernathy	47,233,098	--	--	599,599	1,079,553	Majority: yes
Elect Director: Diane M. Bryant	47,637,507	--	--	195,190	1,079,553	Majority: yes
Elect Director: Michael J. Coyle	47,492,931	--	--	339,766	1,079,553	Majority: yes
Elect Director: Charles J. Dockendorff	46,789,643	--	--	1,043,054	1,079,553	Majority: yes
Elect Director: Lloyd E. Johnson	47,243,880	--	--	588,817	1,079,553	Majority: yes
Elect Director: Mark W. Kroll	46,938,807	--	--	893,890	1,079,553	Majority: yes
Elect Director: Claire Pomeroy	47,553,094	--	--	279,603	1,079,553	Majority: yes
Elect Director: Ellen M. Zane	47,122,780	--	--	709,917	1,079,553	Majority: yes
Proposal 2: The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:	46,230,466	1,460,004	142,227	--	1,079,553	Majority: yes
Proposal 3: The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes:	47,738,769	1,049,682	123,799	--	--	Majority: yes

Source: HAEMONETICS CORP., Form 8-K, filed with the SEC on 2024-07-25 — read the filing on EDGAR.

How asset managers voted at the HAEMONETICS CORP. 2024-2025 meeting

Each item below shows how the 353 asset managers that disclosed a HAEMONETICS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on an advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 8 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 46,230,466AGAINST: 1,460,004

HAEMONETICS CORP.’s own tally for this item (“Proposal 2: The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”): 46,230,466 for, 1,460,004 against, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 90% for, 3% against (93% of the company cast a for/against vote).

The 340 asset managers below cast 98% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 98%

FOR: 98.3%AGAINST: 1.5%ABSTAIN: 0.2%NOT VOTED: 0.0%

Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Against	Vote
Capital Research Global Investors	6,784,216	0	For
Vanguard	6,381,812	0	For
Neuberger Berman	5,977,147	0	For
BlackRock	4,825,956	6,441	For
Capital Group	3,682,187	0	For
T. Rowe Price	3,311,393	0	For
Wellington	3,086,572	0	For
AMCAP FUND	3,053,480	0	For
State Street	2,079,710	52	For
Thrivent	1,621,872	0	For
Fidelity	1,473,930	0	For
FRANKLIN ADVISERS INC	1,271,175	0	For
GEODE CAPITAL MANAGEMENT, LLC	1,137,440	0	For
Royce	1,125,511	0	For
Charles Schwab	1,087,680	0	For
Allspring	880,868	0	For
Dimensional	878,727	0	For
Franklin Custodian Funds	737,264	0	For
SCHRODER INVESTMENT MANAGEMENT GROUP	733,017	0	For
Northern Trust	644,537	0	For
MELLON INVESTMENTS Corp	551,274	0	For
WESTFIELD CAPITAL MANAGEMENT CO LP	505,649	9,258	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
SILVERCREST ASSET MANAGEMENT GROUP LLC	456,975	13,087	For
Hartford	397,743	0	For

Showing the 25 largest of 340 asset managers. See all 340 in the interactive database.

2. Election of Directors: Charles J. Dockendorff

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 46,789,643WITHHELD: 1,043,054

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Charles J. Dockendorff”): 46,789,643 for, 1,043,054 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 91% for, 2% withheld (94% of the company cast a for/withheld vote).

The 113 asset managers below cast 100% of the shares they voted on this item FOR (31,289,880 for, 0 against).

FOR 99.6%

FOR: 31,289,880 (99.7%)ABSTAIN: 100,978 (0.3%)

Largest asset managers voting on “Election of Directors: Charles J. Dockendorff” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	For
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

3. Election of Directors: Christopher A. Simon

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 47,563,311WITHHELD: 269,386

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Christopher A. Simon”): 47,563,311 for, 269,386 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 93% for, 0.6% withheld (94% of the company cast a for/withheld vote).

The 113 asset managers below cast 100% of the shares they voted on this item FOR (31,373,938 for, 0 against).

FOR 99.9%

FOR: 31,373,938 (99.9%)ABSTAIN: 16,920 (0.1%)

Largest asset managers voting on “Election of Directors: Christopher A. Simon” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	For
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

4. Election of Directors: Claire Pomeroy

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 47,553,094WITHHELD: 279,603

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Claire Pomeroy”): 47,553,094 for, 279,603 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 93% for, 0.6% withheld (94% of the company cast a for/withheld vote).

The 113 asset managers below cast 100% of the shares they voted on this item FOR (31,373,126 for, 0 against).

FOR 99.9%

FOR: 31,373,126 (99.9%)ABSTAIN: 17,732 (0.1%)

Largest asset managers voting on “Election of Directors: Claire Pomeroy” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	For
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

5. Election of Directors: Diane M. Bryant

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 47,637,507WITHHELD: 195,190

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Diane M. Bryant”): 47,637,507 for, 195,190 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 93% for, 0.4% withheld (94% of the company cast a for/withheld vote).

The 113 asset managers below cast 100% of the shares they voted on this item FOR (31,373,126 for, 0 against).

FOR 99.9%

FOR: 31,373,126 (99.9%)ABSTAIN: 17,732 (0.1%)

Largest asset managers voting on “Election of Directors: Diane M. Bryant” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	For
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

6. Election of Directors: Ellen M. Zane

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 47,122,780WITHHELD: 709,917

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Ellen M. Zane”): 47,122,780 for, 709,917 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 92% for, 1% withheld (94% of the company cast a for/withheld vote).

The 113 asset managers below cast 100% of the shares they voted on this item FOR (31,284,178 for, 0 against).

FOR 99.6%

FOR: 31,284,178 (99.7%)ABSTAIN: 106,680 (0.3%)

Largest asset managers voting on “Election of Directors: Ellen M. Zane” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	For
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

7. Election of Directors: Lloyd E. Johnson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 47,243,880WITHHELD: 588,817

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Lloyd E. Johnson”): 47,243,880 for, 588,817 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 92% for, 1% withheld (94% of the company cast a for/withheld vote).

The 113 asset managers below cast 100% of the shares they voted on this item FOR (31,337,247 for, 0 against).

FOR 99.8%

FOR: 31,337,247 (99.8%)ABSTAIN: 53,611 (0.2%)

Largest asset managers voting on “Election of Directors: Lloyd E. Johnson” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	For
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

8. Election of Directors: Mark W. Kroll

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 46,938,807WITHHELD: 893,890

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Mark W. Kroll”): 46,938,807 for, 893,890 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 92% for, 2% withheld (94% of the company cast a for/withheld vote).

The 113 asset managers below cast 100% of the shares they voted on this item FOR (31,278,536 for, 0 against).

FOR 99.6%

FOR: 31,278,536 (99.6%)ABSTAIN: 112,322 (0.4%)

Largest asset managers voting on “Election of Directors: Mark W. Kroll” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	For
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	130,753	66,859	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

9. Election of Directors: Michael J. Coyle

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%

FOR: 47,492,931WITHHELD: 339,766

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Michael J. Coyle”): 47,492,931 for, 339,766 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 93% for, 0.7% withheld (94% of the company cast a for/withheld vote).

The 113 asset managers below cast 100% of the shares they voted on this item FOR (31,373,938 for, 0 against).

FOR 99.9%

FOR: 31,373,938 (99.9%)ABSTAIN: 16,920 (0.1%)

Largest asset managers voting on “Election of Directors: Michael J. Coyle” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	For
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

10. Election of Directors: Robert E. Abernathy

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 47,233,098WITHHELD: 599,599

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Robert E. Abernathy”): 47,233,098 for, 599,599 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 92% for, 1% withheld (94% of the company cast a for/withheld vote).

The 113 asset managers below cast 100% of the shares they voted on this item FOR (31,311,343 for, 0 against).

FOR 99.7%

FOR: 31,311,343 (99.7%)ABSTAIN: 79,515 (0.3%)

Largest asset managers voting on “Election of Directors: Robert E. Abernathy” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	For
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

11. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending March 29, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2024-07-25.

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 47,738,769AGAINST: 1,049,682

HAEMONETICS CORP.’s own tally for this item (“Proposal 3: The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes:”): 47,738,769 for, 1,049,682 against, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 93% for, 2% against (95% of the company cast a for/against vote).

The 113 asset managers below cast 99.9% of the shares they voted on this item FOR (31,342,447 for, 28,543 against).

FOR 99.8%

FOR: 31,342,447 (99.9%)AGAINST: 28,543 (0.1%)ABSTAIN: 16,920 (0.1%)

Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fi” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	6,196,351	0	For
Capital Group	3,681,875	0	For
BlackRock	3,247,069	0	For
AMCAP FUND	3,053,480	0	For
Neuberger Berman	2,265,105	0	For
Fidelity	1,277,981	0	For
T. Rowe Price	1,206,185	0	For
Royce	1,017,845	0	For
Thrivent	808,322	0	For
Dimensional	763,345	0	For
Franklin Custodian Funds	737,264	0	For
Charles Schwab	542,230	0	For
FRANKLIN STRATEGIC SERIES	485,600	0	For
State Street	399,117	0	For
Hartford	397,743	0	For
Allspring	393,720	0	For
Brighthouse	293,543	16,920	For
BOSTON TRUST WALDEN FUNDS	290,481	0	For
HARBOR FUNDS	275,060	0	For
John Hancock	234,550	0	For
Equitable	205,349	0	For
Bridge Builder Trust	197,612	0	For
HEARTLAND GROUP INC	180,000	0	For
Columbia Threadneedle	160,731	0	For
SCHWARTZ INVESTMENT TRUST	151,000	0	For

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.

12. Advisory Vote to Ratify Named Executive Officers' Compensation

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 43,016,961AGAINST: 585,626

HAEMONETICS CORP.’s own tally for this item (“Proposal 2: The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”): 43,016,961 for, 585,626 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 84% for, 1% against (85% of the company cast a for/against vote).

The 5 asset managers below cast 99.3% of the shares they voted on this item FOR (93,136 for, 639 against).

FOR 99.3%

FOR: 93,136 (99.3%)AGAINST: 639 (0.7%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Against	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	0	For
Desjardins Global Asset Management Inc.	0	637	Against
BRAVE ASSET MANAGEMENT INC	173	0	For
UNIFIED SERIES TRUST	27	0	For
Aletheian Wealth Advisors LLC	0	2	Against

13. ELECTION OF DIRECTOR: CHARLES J. DOCKENDORFF

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 42,588,774WITHHELD: 1,266,543

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Charles J. Dockendorff”): 42,588,774 for, 1,266,543 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 83% for, 2% withheld (86% of the company cast a for/withheld vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (92,963 for, 0 against).

FOR 99.9%

FOR: 92,963 (100.0%)ABSTAIN: 2 (0.0%)

Largest asset managers voting on “ELECTION OF DIRECTOR: CHARLES J. DOCKENDORFF” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	0	For
UNIFIED SERIES TRUST	27	0	For
Aletheian Wealth Advisors LLC	0	2	Abstain

14. ELECTION OF DIRECTOR: CHRISTOPHER A. SIMON

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%

FOR: 43,756,151WITHHELD: 99,166

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Christopher A. Simon”): 43,756,151 for, 99,166 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 86% for, 0.2% withheld (86% of the company cast a for/withheld vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (92,965 for, 0 against).

FOR 100%

FOR: 92,965 (100.0%)

Largest asset managers voting on “ELECTION OF DIRECTOR: CHRISTOPHER A. SIMON” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	For
UNIFIED SERIES TRUST	27	For
Aletheian Wealth Advisors LLC	2	For

15. ELECTION OF DIRECTOR: CLAIRE POMEROY

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%

FOR: 43,567,795WITHHELD: 287,522

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Claire Pomeroy”): 43,567,795 for, 287,522 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 85% for, 0.6% withheld (86% of the company cast a for/withheld vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (92,963 for, 0 against).

FOR 99.9%

FOR: 92,963 (100.0%)ABSTAIN: 2 (0.0%)

Largest asset managers voting on “ELECTION OF DIRECTOR: CLAIRE POMEROY” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	0	For
UNIFIED SERIES TRUST	27	0	For
Aletheian Wealth Advisors LLC	0	2	Abstain

16. ELECTION OF DIRECTOR: DIANE M. BRYANT

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%

FOR: 43,568,258WITHHELD: 287,059

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Diane M. Bryant”): 43,568,258 for, 287,059 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 85% for, 0.6% withheld (86% of the company cast a for/withheld vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (92,963 for, 0 against).

FOR 99.9%

FOR: 92,963 (100.0%)ABSTAIN: 2 (0.0%)

Largest asset managers voting on “ELECTION OF DIRECTOR: DIANE M. BRYANT” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	0	For
UNIFIED SERIES TRUST	27	0	For
Aletheian Wealth Advisors LLC	0	2	Abstain

17. ELECTION OF DIRECTOR: ELLEN M. ZANE

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 43,066,065WITHHELD: 789,252

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Ellen M. Zane”): 43,066,065 for, 789,252 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 84% for, 2% withheld (86% of the company cast a for/withheld vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (92,963 for, 0 against).

FOR 99.9%

FOR: 92,963 (100.0%)ABSTAIN: 2 (0.0%)

Largest asset managers voting on “ELECTION OF DIRECTOR: ELLEN M. ZANE” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	0	For
UNIFIED SERIES TRUST	27	0	For
Aletheian Wealth Advisors LLC	0	2	Abstain

18. ELECTION OF DIRECTOR: LLOYD E. JOHNSON

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 43,151,041WITHHELD: 704,276

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Lloyd E. Johnson”): 43,151,041 for, 704,276 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 84% for, 1% withheld (86% of the company cast a for/withheld vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (92,965 for, 0 against).

FOR 100%

FOR: 92,965 (100.0%)

Largest asset managers voting on “ELECTION OF DIRECTOR: LLOYD E. JOHNSON” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	For
UNIFIED SERIES TRUST	27	For
Aletheian Wealth Advisors LLC	2	For

19. ELECTION OF DIRECTOR: MARK W. KROLL

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 42,739,455WITHHELD: 1,115,862

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Mark W. Kroll”): 42,739,455 for, 1,115,862 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 84% for, 2% withheld (86% of the company cast a for/withheld vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (92,963 for, 0 against).

FOR 99.9%

FOR: 92,963 (100.0%)ABSTAIN: 2 (0.0%)

Largest asset managers voting on “ELECTION OF DIRECTOR: MARK W. KROLL” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	0	For
UNIFIED SERIES TRUST	27	0	For
Aletheian Wealth Advisors LLC	0	2	Abstain

20. ELECTION OF DIRECTOR: MICHAEL J. COYLE

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 43,670,835WITHHELD: 184,482

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Michael J. Coyle”): 43,670,835 for, 184,482 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 85% for, 0.4% withheld (86% of the company cast a for/withheld vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (92,965 for, 0 against).

FOR 100%

FOR: 92,965 (100.0%)

Largest asset managers voting on “ELECTION OF DIRECTOR: MICHAEL J. COYLE” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	For
UNIFIED SERIES TRUST	27	For
Aletheian Wealth Advisors LLC	2	For

21. ELECTION OF DIRECTOR: ROBERT E. ABERNATHY

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 43,061,317WITHHELD: 794,000

HAEMONETICS CORP.’s own tally for this item (“Elect Director: Robert E. Abernathy”): 43,061,317 for, 794,000 withheld, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 84% for, 2% withheld (86% of the company cast a for/withheld vote).

The 3 asset managers below cast 100% of the shares they voted on this item FOR (92,963 for, 0 against).

FOR 99.9%

FOR: 92,963 (100.0%)ABSTAIN: 2 (0.0%)

Largest asset managers voting on “ELECTION OF DIRECTOR: ROBERT E. ABERNATHY” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Abstain	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	0	For
UNIFIED SERIES TRUST	27	0	For
Aletheian Wealth Advisors LLC	0	2	Abstain

22. TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING MARCH 28, 2026.

INVESTMENT COMPANY MATTERSMajority of the votes cast: yes

Meeting held 2025-07-24 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 43,843,396AGAINST: 1,525,114

HAEMONETICS CORP.’s own tally for this item (“Proposal 3: The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 28, 2026 based upon the following votes:”): 43,843,396 for, 1,525,114 against, per its Form 8-K filed 2025-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 86% for, 3% against (89% of the company cast a for/against vote).

The 3 asset managers below cast 99.9% of the shares they voted on this item FOR (92,963 for, 2 against).

FOR 99.9%

FOR: 92,963 (100.0%)AGAINST: 2 (0.0%)

Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FI” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Against	Vote
NORTHERN LIGHTS FUND TRUST II	92,936	0	For
UNIFIED SERIES TRUST	27	0	For
Aletheian Wealth Advisors LLC	0	2	Against

23. To approve, on an advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2023-08-04 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 44,958,577AGAINST: 1,776,928

HAEMONETICS CORP.’s own tally for this item (“Proposal 2: The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”): 44,958,577 for, 1,776,928 against, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 51,152,886 outstanding shares: 88% for, 3% against (91% of the company cast a for/against vote).

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 723 against).

AGAINST 100%

AGAINST: 723 (100.0%)

Largest asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers.” at HAEMONETICS CORP., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
COLDSTREAM CAPITAL MANAGEMENT INC	0	723	0	0	Against
Echo45 Advisors LLC	0	0	0	0	--

Largest HAEMONETICS CORP. shareholders voting in 2024-2025

Ranked by the number of HAEMONETICS CORP. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 51,152,886 shares outstanding at the time of that meeting.

Top HAEMONETICS CORP. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Capital Research Global Investors	13.26%
2	Vanguard	12.48%
3	Neuberger Berman	11.68%
4	BlackRock	9.45%
5	Capital Group	7.20%
6	T. Rowe Price	6.47%
7	Wellington	6.03%
8	AMCAP FUND	5.97%
9	State Street	4.07%
10	Thrivent	3.17%

Reported HAEMONETICS CORP. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

HAEMONETICS CORP. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	12.43%	13F
Vanguard Group	9.97%	13F
Neuberger Berman Group LLC	6.90%	DEF14A
AQR Capital Management, LLC	6.18%	13G
Vanguard Portfolio Management	5.08%	13G
Wellington Management Group LLP	4.31%	13G
T. Rowe Price Investment Management, Inc.	4.29%	13G
State Street	3.75%	13F
Geode Capital	2.39%	13F
Dimensional Fund Advisors	2.08%	13F

Percentages above are of 51,152,886 shares outstanding, as reported by HAEMONETICS CORP. on its Form 10-Q dated 2024-06-29 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HAEMONETICS CORP.’s 10-Q dated 2024-06-29. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At HAEMONETICS CORP.'s shareholder meeting held 2024-07-25, in the 2024-2025 proxy season, 353 asset managers reported how they voted on 23 ballot items in their SEC Form N-PX filings, covering 4,903 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: HAEMONETICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-07-25.

HAEMONETICS CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.